Downregulation of TfR1 promotes progression of colorectal cancer via the JAK/STAT pathway

References

• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68(1):7–30. doi:10.3322/caac.2144229313949
   PubMed Web of Science ®Google Scholar
• Holmes D. A disease of growth. Nature. 2015;521(7551):S2–S3. doi:10.1038/521S2a25970455
   PubMed Web of Science ®Google Scholar
• Bailey CE, Hu CY, You YN, et al. Increasing disparities in the age-related incidences of colon and rectal cancers in the United States, 1975–2010. JAMA Surg. 2015;150(1):17–22. doi:10.1001/jamasurg.2014.175625372703
   PubMed Web of Science ®Google Scholar
• Daniels TR, Delgado T, Rodriguez JA, Helguera G, Penichet ML. The transferrin receptor part I: biology and targeting with cytotoxic antibodies for the treatment of cancer. Clin Immunol. 2006;121(2):144–158. doi:10.1016/j.clim.2006.06.01016904380
   PubMed Web of Science ®Google Scholar
• Richardson DR, Kalinowski DS, Lau S, Jansson PJ, Lovejoy DB. Cancer cell iron metabolism and the development of potent iron chelators as anti-tumour agents. Biochim Biophys Acta. 2009;1790(7):702–717. doi:10.1016/j.bbagen.2008.04.00318485918
   PubMed Web of Science ®Google Scholar
• Omary MB, Trowbridge IS, Minowada J. Human cell-surface glycoprotein with unusual properties. Nature. 1980;286(5776):888–891.7412870
   PubMed Web of Science ®Google Scholar
• Faulk WP, Hsi BL, Stevens PJ. Transferrin and transferrin receptors in carcinoma of the breast. Lancet. 1980;2(8191):390–392.6105517
   PubMed Web of Science ®Google Scholar
• Sutherland R, Delia D, Schneider C, Newman R, Kemshead J, Greaves M. Ubiquitous cell-surface glycoprotein on tumor cells is proliferation-associated receptor for transferrin. Proc Natl Acad Sci U S A. 1981;78(7):4515–4519. doi:10.1073/pnas.78.7.45156270680
   PubMed Web of Science ®Google Scholar
• Kondo K, Noguchi M, Mukai K, et al. Transferrin receptor expression in adenocarcinoma of the lung as a histopathologic indicator of prognosis. Chest. 1990;97(6):1367–1371.2189695
   PubMed Web of Science ®Google Scholar
• Sciot R, Paterson AC, van Eyken P, Callea F, Kew MC, Desmet VJ. Transferrin receptor expression in human hepatocellular carcinoma: an immunohistochemical study of 34 cases. Histopathology. 1988;12(1):53–63.2836292
   PubMed Web of Science ®Google Scholar
• Ryschich E, Huszty G, Knaebel HP, Hartel M, Buchler MW, Schmidt J. Transferrin receptor is a marker of malignant phenotype in human pancreatic cancer and in neuroendocrine carcinoma of the pancreas. Eur J Cancer. 2004;40(9):1418–1422. doi:10.1016/j.ejca.2004.01.03615177502
   PubMed Web of Science ®Google Scholar
• Jeong SM, Hwang S, Seong RH. Transferrin receptor regulates pancreatic cancer growth by modulating mitochondrial respiration and ROS generation. Biochem Biophys Res Commun. 2016;471(3):373–379. doi:10.1016/j.bbrc.2016.02.02326869514
   PubMed Web of Science ®Google Scholar
• Jeong SM, Lee J, Finley LW, Schmidt PJ, Fleming MD, Haigis MC. SIRT3 regulates cellular iron metabolism and cancer growth by repressing iron regulatory protein 1. Oncogene. 2015;34(16):2115–2124. doi:10.1038/onc.2014.12424909164
   PubMed Web of Science ®Google Scholar
• Yang DC, Wang F, Elliott RL, Head JF. Expression of transferrin receptor and ferritin H-chain mRNA are associated with clinical and histopathological prognostic indicators in breast cancer. Anticancer Res. 2001;21(1b):541–549.11299801
   PubMed Web of Science ®Google Scholar
• Magro G, Cataldo I, Amico P, et al. Aberrant expression of TfR1/CD71 in thyroid carcinomas identifies a novel potential diagnostic marker and therapeutic target. Thyroid. 2011;21(3):267–277. doi:10.1089/thy.2010.017321323588
   PubMed Web of Science ®Google Scholar
• Prutki M, Poljak-Blazi M, Jakopovic M, Tomas D, Stipancic I, Zarkovic N. Altered iron metabolism, transferrin receptor 1 and ferritin in patients with colon cancer. Cancer Lett. 2006;238(2):188–196. doi:10.1016/j.canlet.2005.07.00116111806
   PubMed Web of Science ®Google Scholar
• Brookes MJ, Hughes S, Turner FE, et al. Modulation of iron transport proteins in human colorectal carcinogenesis. Gut. 2006;55(10):1449–1460. doi:10.1136/gut.2006.09406016641131
   PubMed Web of Science ®Google Scholar
• Thomas SJ, Snowden JA, Zeidler MP, Danson SJ. The role of JAK/STAT signalling in the pathogenesis, prognosis and treatment of solid tumours. Br J Cancer. 2015;113(3):365–371. doi:10.1038/bjc.2015.23326151455
   PubMed Web of Science ®Google Scholar
• Spano J-P, Milano G, Rixe C, Fagard R. JAK/STAT signalling pathway in colorectal cancer: A new biological target with therapeutic implications. Eur J Cancer. 2006;42(16):2668–2670. doi:10.1016/j.ejca.2006.07.00616963263
   PubMed Web of Science ®Google Scholar
• Bromberg J. Stat proteins and oncogenesis. J Clin Invest. 2002;109(9):1139–1142. doi:10.1172/JCI1561711994401
   PubMed Web of Science ®Google Scholar
• Lu H, Wu S, Chen H, et al. Crizotinib induces apoptosis of lung cancer cells through JAK-STAT pathway. Oncol Lett. 2018;16(5):5992–5996. doi:10.3892/ol.2018.938730333870
   PubMed Web of Science ®Google Scholar
• Li M, Zheng R, Yuan FL. MiR-410 affects the proliferation and apoptosis of lung cancer A549 cells through regulation of SOCS3/JAK-STAT signaling pathway. Eur Rev Med Pharmacol Sci. 2018;22(18):5987–5993. doi:10.26355/eurrev_201809_1593330280781
   PubMed Web of Science ®Google Scholar
• Pappa E, Nikitakis N, Vlachodimitropoulos D, Avgoustidis D, Oktseloglou V, Papadogeorgakis N. Phosphorylated signal transducer and activator of transcription-1 immunohistochemical expression is associated with improved survival in patients with oral squamous cell carcinoma. J Oral Maxillofac Surg. 2014;72(1):211–221. doi:10.1016/j.joms.2013.06.19823992782
   PubMed Web of Science ®Google Scholar
• Hu Y, Hong Y, Xu Y, Liu P, Guo DH, Chen Y. Inhibition of the JAK/STAT pathway with ruxolitinib overcomes cisplatin resistance in non-small-cell lung cancer NSCLC. Apoptosis. 2014;19(11):1627–1636. doi:10.1007/s10495-014-1030-z25213670
   PubMed Web of Science ®Google Scholar
• Proietti C, Salatino M, Rosemblit C, et al. Progestins induce transcriptional activation of signal transducer and activator of transcription 3 (Stat3) via a Jak- and Src-dependent mechanism in breast cancer cells. Mol Cell Biol. 2005;25(12):4826–4840. doi:10.1128/MCB.25.12.4826-4840.200515923602
   PubMed Web of Science ®Google Scholar
• Leeman RJ, Lui VW, Grandis JR. STAT3 as a therapeutic target in head and neck cancer. Expert Opin Biol Ther. 2006;6(3):231–241. doi:10.1517/14712598.6.3.23116503733
   PubMed Web of Science ®Google Scholar
• Theil EC. Ferritin: structure, gene regulation, and cellular function in animals, plants, and microorganisms. Annu Rev Biochem. 1987;56:289–315. doi:10.1146/annurev.bi.56.070187.0014453304136
   PubMed Web of Science ®Google Scholar
• Li L, Fang CJ, Ryan JC, et al. Binding and uptake of H-ferritin are mediated by human transferrin receptor-1. Proc Natl Acad Sci U S A. 2010;107(8):3505–3510. doi:10.1073/pnas.091319210720133674
   PubMed Web of Science ®Google Scholar
• Fan K, Cao C, Pan Y, et al. Magnetoferritin nanoparticles for targeting and visualizing tumour tissues. Nat Nanotechnol. 2012;7(7):459–464. doi:10.1038/nnano.2012.9022706697
   PubMed Web of Science ®Google Scholar
• Marullo M, Zuccato C, Mariotti C, et al. Expressed Alu repeats as a novel, reliable tool for normalization of real-time quantitative RT-PCR data. Genome Biol. 2010;11(1):R9. doi:10.1186/gb-2010-11-11-r11020109193
   PubMed Web of Science ®Google Scholar
• Vasaikar SV, Straub P, Wang J, Zhang B. LinkedOmics: analyzing multi-omics data within and across 32 cancer types. Nucleic Acids Res. 2018;46(D1):D956–d963. doi:10.1093/nar/gkx109029136207
   PubMed Web of Science ®Google Scholar
• Zhang Y, Tian X, Ji H, et al. Expression of SATB1 promotes the growth and metastasis of colorectal cancer. PLoS One. 2014;9(6):e100413. doi:10.1371/journal.pone.010041324971456
   PubMed Web of Science ®Google Scholar
• Daniels TR, Bernabeu E, Rodriguez JA, et al. The transferrin receptor and the targeted delivery of therapeutic agents against cancer. Biochim Biophys Acta. 2012;1820(3):291–317. doi:10.1016/j.bbagen.2011.07.01621851850
   PubMed Web of Science ®Google Scholar
• Ludwig H, Evstatiev R, Kornek G, et al. Iron metabolism and iron supplementation in cancer patients. Wien Klin Wochenschr. 2015;127(23–24):907–919. doi:10.1007/s00508-015-0842-326373748
   PubMed Web of Science ®Google Scholar
• Chan KT, Choi MY, Lai KK, et al. Overexpression of transferrin receptor CD71 and its tumorigenic properties in esophageal squamous cell carcinoma. Oncol Rep. 2014;31(3):1296–1304. doi:10.3892/or.2014.298124435655
   PubMed Web of Science ®Google Scholar
• Hanninen MM, Haapasalo J, Haapasalo H, et al. Expression of iron-related genes in human brain and brain tumors. BMC Neurosci. 2009;10:36. doi:10.1186/1471-2202-10-3619386095
   PubMed Web of Science ®Google Scholar
• Jiang XP, Elliott RL, Head JF. Manipulation of iron transporter genes results in the suppression of human and mouse mammary adenocarcinomas. Anticancer Res. 2010;30(3):759–765.20392994
   PubMed Web of Science ®Google Scholar
• Wang W, Deng Z, Hatcher H, et al. IRP2 regulates breast tumor growth. Cancer Res. 2014;74(2):497–507. doi:10.1158/0008-5472.CAN-13-122424285726
   PubMed Web of Science ®Google Scholar
• O’Donnell KA, Yu D, Zeller KI, et al. Activation of transferrin receptor 1 by c-Myc enhances cellular proliferation and tumorigenesis. Mol Cell Biol. 2006;26(6):2373–2386. doi:10.1128/MCB.26.6.2373-2386.200616508012
   PubMed Web of Science ®Google Scholar
• Yang P, Cunningham JM, Halling KC, et al. Higher risk of mismatch repair-deficient colorectal cancer in alpha(1)-antitrypsin deficiency carriers and cigarette smokers. Mol Genet Metab. 2000;71(4):639–645. doi:10.1006/mgme.2000.308911136557
   PubMed Web of Science ®Google Scholar
• Graziadei I, Gaggl S, Kaserbacher R, Braunsteiner H, Vogel W. The acute-phase protein alpha 1-antitrypsin inhibits growth and proliferation of human early erythroid progenitor cells (burst-forming units-erythroid) and of human erythroleukemic cells (K562) in vitro by interfering with transferrin iron uptake. Blood. 1994;83(1):260–268.7506082
   PubMed Web of Science ®Google Scholar
• Adachi M, Kai K, Yamaji K, et al. Transferrin receptor 1 overexpression is associated with tumor dedifferentiation and acts as a potential prognostic indicator of hepatocellular carcinoma. Histopathology. 2019. doi:10.1111/his.13847
   PubMed Web of Science ®Google Scholar
• Greene CJ, Attwood K, Sharma NJ, et al. Transferrin receptor 1 upregulation in primary tumor and downregulation in benign kidney is associated with progression and mortality in renal cell carcinoma patients. Oncotarget. 2017;8(63):107052–107075. doi:10.18632/oncotarget.2232329291011
   PubMedGoogle Scholar
• Senesse P, Meance S, Cottet V, Faivre J, Boutron-Ruault MC. High dietary iron and copper and risk of colorectal cancer: a case-control study in Burgundy, France. Nutr Cancer. 2004;49(1):66–71. doi:10.1207/s15327914nc4901_915456637
   PubMed Web of Science ®Google Scholar
• Xue X, Shah YM. Intestinal iron homeostasis and colon tumorigenesis. Nutrients. 2013;5(7):2333–2351. doi:10.3390/nu507233323812305
   PubMed Web of Science ®Google Scholar
• Chua AC, Klopcic B, Lawrance IC, Olynyk JK, Trinder D. Iron: an emerging factor in colorectal carcinogenesis. World J Gastroenterol. 2010;16(6):663–672. doi:10.3748/wjg.v16.i6.66320135713
   PubMed Web of Science ®Google Scholar
• Kishida T, Shinozawa I, Tanaka S, et al. Significance of serum iron and ferritin in patients with colorectal adenomas. Scand J Gastroenterol. 1997;32(3):233–237.9085460
   PubMed Web of Science ®Google Scholar
• Ohkuma M, Haraguchi N, Ishii H, et al. Absence of CD71 transferrin receptor characterizes human gastric adenosquamous carcinoma stem cells. Ann Surg Oncol. 2011;19(4):1357–1364. doi:10.1245/s10434-011-1739-721523522
   PubMed Web of Science ®Google Scholar
• Tyagi A, Vishnoi K, Mahata S, et al. Cervical cancer stem cells selectively overexpress HPV oncoprotein E6 that controls stemness and self-renewal through upregulation of HES1. Clin Cancer Res. 2016;22(16):4170–4184. doi:10.1158/1078-0432.CCR-15-257426988248
   PubMed Web of Science ®Google Scholar
• Liang M, Fan K, Zhou M, et al. H-ferritin-nanocaged doxorubicin nanoparticles specifically target and kill tumors with a single-dose injection. Proc Natl Acad Sci U S A. 2014;111(41):14900–14905. doi:10.1073/pnas.140780811125267615
   PubMed Web of Science ®Google Scholar
• Fan K, Xi J, Fan L, et al. In vivo guiding nitrogen-doped carbon nanozyme for tumor catalytic therapy. Nat Commun. 2018;9(1):1440. doi:10.1038/s41467-018-03903-829650959
   PubMedGoogle Scholar
• Fan K, Jia X, Zhou M, et al. Ferritin nanocarrier traverses the blood brain barrier and kills glioma. ACS Nano. 2018;12(5):4105–4115. doi:10.1021/acsnano.7b0696929608290
   PubMed Web of Science ®Google Scholar